Henry Schein Inc 's Revenue in the fiscal year 2025 $ 13,184.00 millions
Henry Schein Inc 's Revenue in the fiscal year 2024 $ 12,673.00 millions
Henry Schein Inc 's Revenue in the fiscal year 2023 $ 12,339.00 millions
Henry Schein Inc 's Revenue in the fiscal year 2022 $ 12,647.00 millions
Henry Schein Inc 's Revenue in the fiscal year 2021 $ 12,401.02 millions
HSIC Revenue second quarter 2026 Y/Y Growth Comment
Henry Schein Inc reported Revenue growth of 6.73% year on year in the second quarter 2026, to $ 3,458.00 millions, this is lower than Henry Schein Inc 's recent average Revenue increase of 11.52%.
Looking into second quarter 2026 results within Medical Equipment & Supplies industry 131 other companies have achieved higher Revenue growth. While Henry Schein Inc ' s Revenue increase of 6.73% ranks overall at the positon no. 2464 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Henry Schein Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
68.61 %
1.49 %
-30.65 %
(Sep 26 2020)
HSIC's II. Quarter Q/Q Revenue Comment
Henry Schein Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 2.67%, to $ 3,458.00 millions, from $3,368.00 millions in the first quarter. HSIC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Henry Schein Inc 's Revenue growth quarter on quarter, overall rank is 1314.
Henry Schein Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 2.67%, to $ 3,458.00 millions, from $3,368.00 millions in the first quarter. HSIC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Henry Schein Inc 's Revenue growth quarter on quarter, overall rank is 1314.
Henry Schein Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 27 2026)
12 Months Ending (Mar 28 2026)
12 Months Ending (Dec 27 2025)
12 Months Ending (Sep 27 2025)
12 Months Ending (Jun 28 2025)
Cumulative Revenue 12 Months Ending
$ 13,602.00
$ 13,384.00
$ 13,184.00
$ 12,938.00
$ 12,773.00
Y / Y Revenue Growth (TTM)
6.49 %
5.64 %
4.03 %
3.51 %
2.29 %
Year on Year Revenue Growth Overall
Ranking
# 2290
# 1997
# 1502
# 1675
# 1558
Seqeuential Revenue Change (TTM)
1.63 %
1.52 %
1.9 %
1.29 %
0.82 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2464
# 2149
# 1611
# 1549
# 1484
Cumulative Revenue growth Comment
Although Henry Schein Inc 's Annual Revenue growth year on year were below company's average 11.52% , Revenue announced in the Jun 27 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 6.49% year on year, from 5.64% in Mar 28 2026.
In the Healthcare sector 333 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1997 to 2290.
Although Henry Schein Inc 's Annual Revenue growth year on year were below company's average 11.52% , Revenue announced in the Jun 27 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 6.49% year on year, from 5.64% in Mar 28 2026.
In the Healthcare sector 333 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1997 to 2290.
About Henry Schein Inc Revenue Growth Rates (HSIC), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
11.60%